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ABSTRACT
Eleven isolates of Enterococcus faecalis causing
endocarditis were screened for possible virulence
factors with PCR and phenotypic assays. The
gene coding for the enterococcal surface protein
(esp) was detected in one isolate only, and
haemolysin was produced by two isolates. Aggre-
gation substance, biofilm formation and gela-
tinase were present in seven, nine and eight
isolates, respectively. Predisposing factors, partic-
ularly hospitalisation and multiple antibiotic
therapy, appeared to be more relevant to the
development of enterococcal endocarditis follow-
ing bloodstream infections than the pattern of
virulence factors.
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Enterococci are recognised nosocomial pathogens,
with Enterococcus faecalis and Enterococcus faecium
being responsible for a large proportion of urin-
ary tract and bloodstream infections in intensive
care units. Endocarditis is a well-known compli-
cation of enterococcal bacteraemia that typically
occurs on damaged (native valve endocarditis) or
prosthetic (prosthetic valve endocarditis) heart
valves. Infective endocarditis can lead to damage
or destruction of heart valves, resulting, in the
most severe cases, in heart failure and death.
Possible enterococcal virulence factors involved
in endocarditis have been reviewed previously
[1], but none of those considered could account
for the development of endocarditis. In a large
collection of clinical and environmental isolates
examined, isolates from urinary tract infections
appeared to possess more virulence factors than
those from other clinical or environmental sources
[2]. In the present study, 11 cases of E. faecalis
endocarditis were investigated. Possible predis-
posing factors and the patients’ conditions were
examined, and the causative isolates were char-
acterised for putative virulence factors.
Cases of endocarditis were classified as ‘defin-
ite endocarditis’ according to the Duke criteria [3].
All patients had been hospitalised at the Policli-
nico of the University ‘La Sapienza’ in Rome,
Italy, over a 4-year period. E. faecalis isolates from
blood were identified and speciated according to
standard methods, and verified by a species-
specific 16S ribosomal PCR [4]. Production of
gelatinase was determined on plates containing
trypticase soy agar supplemented with skimmed
milk 1.5% (w ⁄ v) [5]. Haemolysin production was
evaluated on Columbia agar base supplemented
with fresh human blood 5% v ⁄ v [2]. Biofilm
formation was evaluated with a quantitative
adherence assay as described previously [6]. The
presence of the putative virulence factor genes for
enterococcal surface protein (esp), aggregation
substance (AS) (asa1), collagen-binding adhesin
(ace) and endocarditis antigen (efaA) were inves-
tigated with PCR as described previously [2], with
reference strains being used as positive controls
[2].
The clinical features of the 11 cases of entero-
coccal endocarditis are listed in Table 1. There
were four cases of native valve endocarditis and
seven of prosthetic valve endocarditis. In all but
two cases, predisposing factors were present, of
which hospitalisation and multiple antibiotic
therapy were the most frequent. One isolate was
vancomycin-resistant, while three exhibited high-
level resistance to aminoglycosides (Table 1).
One isolate was esp-positive, seven isolates
were asa1-positive, and ace and efaA were present
in all isolates (Table 2). Haemolysin and gela-
tinase were produced by two and eight isolates,
respectively. Biofilm production was demonstra-
ted with nine isolates. A similar analysis (data not
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shown) conducted on 20 bacteraemia isolates
during the same period in this hospital showed
similar frequencies of the examined factors, with
two exceptions: esp was detected in 50% of cases,
and all isolates demonstrated biofilm formation.
Of particular interest were two isolates charac-
terised in this study (EE3 and EE4) that lacked all
of the putative virulence factors tested except
gelatinase. EE4 caused massive destruction of the
cardiac valves in a man aged 38 years with no
previous history of significant heart disease. The
apparent lack of predisposing conditions would
suggest that EE4 was a particularly aggressive
microorganism, and the valve destruction was
consistent with the ability of this isolate to
produce a protease, which appeared to be the
only possible virulence factor. As for EE3, at least
one of the urinary tract infections documented for
this patient was caused by E. faecalis, so it may be
hypothesised that translocation occurred. Unfor-
tunately, this could not be confirmed, as the urine
isolate was not stored.
Of all the putative virulence factors described
in the literature, AS and extracellular polysaccha-
rides were detected in most of the isolates; no
difference was observed in the distribution of
virulence factors among endocarditis or bacterae-
mia isolates, except for esp, which was more
frequent in the latter group.
Evidence for the role of gelatinase in endocarditis
comes from a rabbit model of catheter-induced
endocarditis, where gelatinase-producing isolates
were associated with a more rapidly fatal disease
[7]. Involvement of AS in virulence has been
suggested by several in-vitro and animal studies
(reviewed in McCormick et al. [1]); in particular,
Chow et al. [5] concluded that AS contributed to an
increase in the size of valve vegetation.
Table 1. Microbiological and clinical features of 11 cases of Enterococcus faecalis endocarditis
Strain Sex ⁄Age
Source of
sepsis ⁄predisposing
factors
Underlying
heart
disease
Site of
infection
Acquired
antibiotic
resistance Therapy Outcome
EE1 M ⁄ 84 TURP, hosp, mat DVD Mitral valve HLRA AMP + CRO,
then TEC
Cured [13]
EE2 F ⁄ 76 hosp RVD Bioprosthetic
mitral valve
– AMP + GEN Cured
EE3 M ⁄ 71 Urethral stenosis
with endoscopic
procedures,
hosp, mat
DVD Aortic valve – AMP + GEN Cured
EE4 M ⁄ 38 None Unknown Mitral valve HLRA AMP + CRO Cureda
EE5 M ⁄ 68 Diverticular disease
with endoscopic
procedures,
hosp, mat
RVD Bioprosthetic
mitral valve
VanA AMP + GEN Cured [14]
EE6 M ⁄ 48 hosp RVD Prosthetic
mitral and
aortic valve
HLRA AMP + GEN Diedb
EE7 M ⁄ 28 IVDU Unknown Mitral valve – TEC + GEN Cured
EE8 M ⁄ 67 Hip arthroplasty,
hosp, mat
DVD Prosthetic
aortic valve
– AMP + GEN Cured
EE9 M ⁄ 69 hosp, mat DVD Prosthetic
aortic valve
HLRA AMP + CRO Cured
EE10 M ⁄ 40 None RVD Prosthetic
aortic valve
– AMP + GEN Cured
EE11 F ⁄ 65 hosp, mat DVD Intraventricular
patch
– AMP + GEN Cured
TURP, trans-urethral prostatectomy; DVD, degenerative valvular disease; RVD, rheumatic valvular disease; hosp, hospitalisation in the previous 6 months; mat, multiple
antibiotic therapy; IVDU, intravenous drug user; HLRA, high-level resistance to aminoglycosides (streptomycin and gentamicin); AMP, ampicillin; CRO, ceftriaxone; GEN,
gentamicin; TEC, teicoplanin.
aSurgical replacement of dysfunctional valve after the end of treatment: no bacterial growth at culture.
bOn the third day of empirical antibiotic treatment, the patient underwent emergency surgical replacement of prosthetic valve and died of cardiogenic shock 2 days after
surgery; culture of the aortic valve yielded E. faecalis growth.
Table 2. Putative virulence factors of endocarditis-causing
Enterococcus faecalis
Strains Biofilm Haemolysin asa1 esp Gelatinase ace EfaA
EE1 + – + – + + +
EE2 + – – – + + +
EE3 – – – – + + +
EE4 – – – – + + +
EE5 + – + – – + +
EE6 + – + – – + +
EE7 + – + – – + +
EE8 + – + – + + +
EE9 + + + – + + +
EE10 + – – – + + +
EE11 + + + + + + +
asa1, aggregation substance; esp, enterococcal surface protein; ace, collagen-binding
adhesin; EfaA, endocarditis antigen.
Research Note 1007
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 1006–1035
A role for biofilm formation in the pathogenesis
of enterococcal infections has also been suggested
[6], with production linked to stress conditions
and survival inside macrophages [6,8,9]. Biofilm
production is known to be important in the
establishment of infections by opportunistic
coagulase-negative staphylococci and Staphylococ-
cus aureus, particularly those infections involving
prosthetic materials.
As in previous studies involving clinical and
environmental isolates [2,10], all the isolates were
ace- and efaA-positive, although expression of ace
or efaA may be modulated in vivo, thus contribu-
ting to the pathogenesis of endocarditis. In addi-
tion, isolates negative for haemolysin and
gelatinase production might still harbour the
respective genes.
In conclusion, the specific pattern of the viru-
lence factors tested does not appear to correlate
with the ability of E. faecalis to cause endocarditis.
Indeed, endocarditis isolates seem to have fewer
virulence factors compared to isolates from other
sources. However, the ability to express specific
traits, such as gelatinase, might correlate with the
ability of strains to cause the disease. Predisposing
factors for the development of endocarditis ap-
peared to be sex (males were more frequently
affected), age and hospitalisation, which con-
firmed previous findings [11,12], as well as under-
lying heart disease and enterococcal bacteraemia.
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